VEA
Virtus ETF Advisers’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,524
| Closed | -$66.5K | – | 364 |
|
|
2024
Q4 | $66.5K | Sell |
8,524
-1,742
| -17% | -$13.6K | 0.03% | 408 |
|
|
2024
Q3 | $111K | Buy |
10,266
+185
| +2% | +$2K | 0.05% | 361 |
|
|
2024
Q2 | $85K | Sell |
10,081
-7,386
| -42% | -$62.3K | 0.04% | 382 |
|
|
2024
Q1 | $117K | Sell |
17,467
-1,199
| -6% | -$8.06K | 0.06% | 348 |
|
|
2023
Q4 | $110K | Buy |
18,666
+10,966
| +142% | +$64.5K | 0.07% | 330 |
|
|
2023
Q3 | $75.1K | Sell |
7,700
-762
| -9% | -$7.43K | 0.05% | 373 |
|
|
2023
Q2 | $100K | Buy |
8,462
+95
| +1% | +$1.13K | 0.06% | 380 |
|
|
2023
Q1 | $90.3K | Sell |
8,367
-3,209
| -28% | -$34.6K | 0.05% | 364 |
|
|
2022
Q4 | $134K | Buy |
+11,576
| New | +$134K | 0.07% | 383 |
|
|
2022
Q2 | – | Sell |
-19,452
| Closed | -$146K | – | 448 |
|
|
2022
Q1 | $146K | Sell |
19,452
-1,158
| -6% | -$8.69K | 0.07% | 228 |
|
|
2021
Q4 | $177K | Sell |
20,610
-2,725
| -12% | -$23.4K | 0.07% | 256 |
|
|
2021
Q3 | $196K | Sell |
23,335
-1,219
| -5% | -$10.2K | 0.09% | 274 |
|
|
2021
Q2 | $199K | Sell |
24,554
-3,547
| -13% | -$28.7K | 0.08% | 351 |
|
|
2021
Q1 | $247K | Buy |
+28,101
| New | +$247K | 0.1% | 292 |
|